Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $967 | $786 | $31,109 |
| - Cash | $18,692 | $24,287 | $31,029 | $8,636 |
| + Debt | $1,529 | $3,374 | $3,478 | $3,664 |
| Enterprise Value | – | -$19,946 | -$26,765 | $26,137 |
| Revenue | $260 | $518 | $2,138 | $1,486 |
| % Growth | -49.8% | -75.8% | 43.9% | – |
| Gross Profit | $139 | $350 | $1,325 | $595 |
| % Margin | 53.5% | 67.6% | 62% | 40% |
| EBITDA | -$10,241 | -$9,158 | -$6,151 | -$32,918 |
| % Margin | -3,938.8% | -1,768% | -287.7% | -2,215.2% |
| Net Income | -$10,854 | -$9,742 | -$6,671 | -$33,511 |
| % Margin | -4,174.6% | -1,880.7% | -312% | -2,255.1% |
| EPS Diluted | -0.34 | -0.304 | -0.26 | -1.928 |
| % Growth | -11.8% | -17.2% | 86.5% | – |
| Operating Cash Flow | -$4,502 | -$6,279 | -$5,858 | -$5,354 |
| Capital Expenditures | -$1,050 | -$349 | -$307 | -$214 |
| Free Cash Flow | -$5,552 | -$6,628 | -$6,165 | -$5,568 |